Drug intelligence / Profile preview

Rubedo Life Sciences Unnamed Oncology Program

Development stage: Preclinical
Lead developer: Rubedo Life Sciences
Modality: Small Molecules
Administration: Topical, Systemic

Overview

Rubedo Life Sciences' Unnamed Oncology Program is a preclinical-stage therapeutic candidate being developed for the treatment of non-small cell lung cancer (NSCLC). Utilizing Rubedo's proprietary senescence-targeting platform, the program aims to identify and selectively target specific cell populations, such as senescent-like cancer cells, that drive disease progression and resistance. The approach involves senolytic or senomorphic mechanisms to modulate the tumor microenvironment or directly eliminate problematic cells. By targeting the underlying cellular drivers of aging and disease, the program seeks to improve clinical outcomes and overcome resistance to conventional oncology treatments.

Other names: Unnamed Oncology ProgramRubedo Life Sciences-Cancer Cells-Non-Small Cell Lung Cancer (NSCLC)

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on Rubedo Life Sciences Unnamed Oncology Program.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rubedo Life Sciences Unnamed Oncology Program.

Explore the full profile